Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease
- PMID: 20666992
- DOI: 10.1111/j.1478-3231.2010.02314.x
Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease
Abstract
Aims: Our aim was to develop an accurate, non-invasive, blood-test-based method for identifying the main characteristics of liver fibrosis in non-alcoholic fatty liver disease (NAFLD).
Methods: Fibrosis was staged according to NASH-CRN and Metavir systems in 226 patients with NAFLD. A fully automated algorithm measured the fractal dimension (FD) and the area of fibrosis (AOF). Independent predictors of diagnostic targets were determined using bootstrap methods.
Results: (i) Development. Significant fibrosis defined by NASH-CRN F ≥2 was diagnosed by weight, glycaemia, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and prothrombin index [area under the receiver operating characteristic (AUROC)=0.867]; significant fibrosis defined by Metavir F ≥2 was diagnosed by weight, age, glycaemia, AST, ALT, ferritin and platelets (FibroMeter AUROC=0.941, P<0.005). AOF was estimated by the combination of hyaluronic acid, glycaemia, AST, ALT, platelets and prothrombin index ((a) R(2) =0.530), while FD was estimated by hyaluronic acid, glycaemia, AST/ALT, weight and platelets ((a) R(2) =0.529). (ii) Evaluation. Although NASH-CRN was a better system for fibrosis staging, Metavir staging was a better reference for blood test. Thus, the patient rate with predictive values ≥90% by tests was 97.3% with Metavir reference vs. 66.5% with NASH-CRN reference (P<10(-3)). FibroMeter showed a significantly higher AUROC than the NAFLD fibrosis score for significant fibrosis, but not for severe fibrosis or cirrhosis, with both staging systems. Relationships between fibrosis lesions were well reflected by blood tests, e.g., the correlation between histological area and FD of fibrosis (r(s) =0.971, P<10(-3)) was well reflected by the relationship between respective blood tests (r(s) =0.852, P<10(-3)).
Conclusions: Different characteristics of fibrosis in NAFLD can be diagnosed and quantified by blood tests with excellent accuracy.
© 2010 John Wiley & Sons A/S.
Similar articles
-
Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease.Liver Int. 2005 Aug;25(4):779-86. doi: 10.1111/j.1478-3231.2005.01064.x. Liver Int. 2005. PMID: 15998429
-
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.Gut. 2010 Sep;59(9):1265-9. doi: 10.1136/gut.2010.216077. Gut. 2010. PMID: 20801772
-
Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease.J Gastroenterol Hepatol. 2011 Oct;26(10):1536-43. doi: 10.1111/j.1440-1746.2011.06774.x. J Gastroenterol Hepatol. 2011. PMID: 21950746
-
Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease.Clin Liver Dis. 2007 Feb;11(1):25-35, viii. doi: 10.1016/j.cld.2007.02.004. Clin Liver Dis. 2007. PMID: 17544970 Review.
-
Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease.Ann Hepatol. 2009 Apr-Jun;8(2):89-94. Ann Hepatol. 2009. PMID: 19502649 Review.
Cited by
-
High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.BMC Gastroenterol. 2014 Nov 20;14:195. doi: 10.1186/s12876-014-0195-9. BMC Gastroenterol. 2014. PMID: 25410681 Free PMC article.
-
Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms.PLoS One. 2016 Dec 9;11(12):e0167776. doi: 10.1371/journal.pone.0167776. eCollection 2016. PLoS One. 2016. PMID: 27936091 Free PMC article.
-
Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease.Front Med (Lausanne). 2020 Dec 18;7:616212. doi: 10.3389/fmed.2020.616212. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33392234 Free PMC article.
-
Cardiometabolic aspects of the polycystic ovary syndrome.Endocr Rev. 2012 Oct;33(5):812-41. doi: 10.1210/er.2012-1003. Epub 2012 Jul 24. Endocr Rev. 2012. PMID: 22829562 Free PMC article. Review.
-
Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.Hepatology. 2012 Jan;55(1):77-85. doi: 10.1002/hep.24706. Epub 2011 Dec 6. Hepatology. 2012. PMID: 21953442 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous